Stramsen Biotech

Houston, United States

Stramsen Biotech is a biopharmaceutical company that uses natural plant based approach to develop medicines.

$25.0M raised

Apr 2025

Series B

Biopharma Medical

Top Investors

The Global Emerging Markets Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Stramsen Biotech

How much funding has Stramsen Biotech raised?

Stramsen Biotech has raised $25.0M in total funding. The most recent round was Series B. The last funding was announced in April 2025.

Who are Stramsen Biotech's investors?

Stramsen Biotech's investors include The Global Emerging Markets Group.

Where is Stramsen Biotech headquartered?

Stramsen Biotech is headquartered in Houston, United States.

What does Stramsen Biotech do?

Stramsen Biotech is a biopharmaceutical company that uses natural plant based approach to develop medicines.

What stage is Stramsen Biotech at?

Stramsen Biotech is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 7, 2025.

MLA

"Stramsen Biotech — Funding & Investors." VCBacked, April 7, 2025, https://www.vcbacked.co/company/stramsen-biotech. Accessed July 2, 2026.

APA

VCBacked. (2025). Stramsen Biotech — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/stramsen-biotech

Wikipedia (cite web)

{{cite web |title=Stramsen Biotech — Funding & Investors |url=https://www.vcbacked.co/company/stramsen-biotech |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 7, 2025.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.